三元生物
(301206)
| 流通市值：31.12亿 | | | 总市值：58.51亿 |
| 流通股本：1.08亿 | | | 总股本：2.02亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 150,204,941.37 | 712,904,207.78 | 514,923,140.19 | 376,846,697.32 |
| 营业收入 | 150,204,941.37 | 712,904,207.78 | 514,923,140.19 | 376,846,697.32 |
| 二、营业总成本 | 140,915,661.83 | 694,776,643.89 | 512,885,968.89 | 377,295,247.03 |
| 营业成本 | 123,708,148.18 | 633,728,502.33 | 461,905,205.46 | 337,636,592.84 |
| 税金及附加 | 817,618.09 | 3,126,317.86 | 2,299,966.27 | 1,570,206.49 |
| 销售费用 | 1,683,681.72 | 6,967,383.73 | 4,612,233.07 | 2,860,244.41 |
| 管理费用 | 7,186,420.27 | 19,747,314.16 | 14,802,242.4 | 10,061,457.4 |
| 研发费用 | 9,744,135.17 | 41,232,951.56 | 35,805,522.37 | 31,943,684.15 |
| 财务费用 | -2,224,341.6 | -10,025,825.75 | -6,539,200.68 | -6,776,938.26 |
| 其中:利息收入 | 1,886,105.67 | 2,828,961.81 | 2,307,365.65 | 1,723,887.72 |
| 加:投资收益 | 19,052,784.16 | 108,578,694.29 | 82,042,245.6 | 55,395,705.58 |
| 资产处置收益 | 1,131.16 | - | - | - |
| 信用减值损失(新) | -849,758.22 | -642,040.27 | -131,791.86 | -39,204.74 |
| 其他收益 | 396,202.98 | 1,880,037.69 | 1,546,304.35 | 846,521.42 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 27,889,639.62 | 127,944,255.6 | 85,493,929.39 | 55,754,472.55 |
| 加:营业外收入 | 21,122.47 | 426,678.1 | 333,769.1 | 208,261.75 |
| 减:营业外支出 | - | 166,576.07 | 84,316.18 | 84,316.18 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 27,910,762.09 | 128,204,357.63 | 85,743,382.31 | 55,878,418.12 |
| 减:所得税费用 | 3,019,073.41 | 23,253,017.46 | 4,736,208.37 | 3,964,660.42 |
| 六、净利润 | 24,891,688.68 | 104,951,340.17 | 81,007,173.94 | 51,913,757.7 |
| 持续经营净利润 | 24,891,688.68 | 104,951,340.17 | 81,007,173.94 | 51,913,757.7 |
| 归属于母公司股东的净利润 | 24,913,986.7 | 104,951,340.17 | 81,007,173.94 | 51,913,757.7 |
| 少数股东损益 | -22,298.02 | - | - | - |
| (一)基本每股收益 | 0.12 | 0.52 | 0.4 | 0.26 |
| (二)稀释每股收益 | 0.12 | 0.52 | 0.4 | 0.26 |
| 九、综合收益总额 | 24,891,688.68 | 104,951,340.17 | 81,007,173.94 | 51,913,757.7 |
| 归属于母公司股东的综合收益总额 | 24,913,986.7 | 104,951,340.17 | 81,007,173.94 | 51,913,757.7 |
| 归属于少数股东的综合收益总额 | -22,298.02 | - | - | - |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |